(en) Harrison G. Pope, Elena M. Kouri, James I. Hudson, « Effects of Supraphysiologic Doses of Testosterone on Mood and Aggression in Normal Men », Med Sci Sports Exerc, Arch Gen Psychiatry, vol. 57, no 2, , p. 133-140. (PMID10665615, lire en ligne, consulté le )
annualreviews.org
(en) R. Marcus et S. Korenman, « Estrogens and the human male », Annual Review of Medicine, vol. 27, , p. 357-70 (PMID779604, lire en ligne)
(en) Chris Woolston, « Ills & Conditions », CONSUMER HEALTH INTERACTIVE, (consulté le )
cbsnews.com
(en) « Teens & Steroids: A Dangerous Mix », CBS, CBS Broadcasting Inc., (lire en ligne, consulté le )
depaul.edu
law.depaul.edu
(en) Philip J. Sweitzer, « Drug law enforcement in crisis: cops on steroids », Journal of Sports Law and Contemporary Problems, vol. 2, no 2, (lire en ligne, consulté le )
dhs.vic.gov.au
(en) « Steroids », North Eastern AIDS Prevention Program, Victoria Australia Department of Human Services (consulté le )
doi.org
dx.doi.org
(en) R. Calfee R, P. Fadale, « Popular ergogenic drugs and supplements in young athletes », Pediatrics, vol. 117, no 3, , e577-89 (PMID16510635, DOI10.1542/peds.2005-1429)
(en) K. Pereira de Jésus-Tran, P. Côté, L. Cantin, J. Blanchet, F. Labrie, R. Breton, « Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity », Protein Sci., vol. 15, no 5, , p. 987-99 (PMID16641486, DOI10.1110/ps.051905906)
(en) D. Lavery, I. McEwan, « Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations », Biochem. J., vol. 391, no Pt 3, , p. 449-64 (PMID16238547, DOI10.1042/BJ20050872, lire en ligne)
(en) B. Melnik, T. Jansen, S.Grabbe, « Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem », Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, vol. 5, no 2, , p. 110-7 (PMID17274777, DOI10.1111/j.1610-0387.2007.06176.x)
(en) L. Socas, M. Zumbado, O. Pérez-Luzardoet al., « Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature », British journal of sports medicine, vol. 39, no 5, , e27 (PMID15849280, DOI10.1136/bjsm.2004.013599)
(en) I. Velazquez, B. Alteret al., « Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions », Am. J. Hematol., vol. 77, no 3, , p. 257-267 (PMID15495253, DOI10.1002/ajh.20183)
(en) K. Nair, R. Rizza, P. O'Brien et al., « DHEA in elderly women and DHEA or testosterone in elderly men », N Engl J Med, vol. 355, no 16, , p. 1647-59 (PMID17050889, DOI10.1056/NEJMoa054629)
(en) S. McCabe, K. Brower, B. West, T. Nelson, H. Wechsler, « Trends in non-medical use of anabolic steroids by U.S. college students: Results from four national surveys », Drug and alcohol dependence, vol. 90, nos 2-3, , p. 243-51 (PMID17512138, DOI10.1016/j.drugalcdep.2007.04.004)
(en) G. Kanayama, S. Barry, J. Hudson, H. Pope, « Body image and attitudes toward male roles in anabolic-androgenic steroid users », The American journal of psychiatry, vol. 163, no 4, , p. 697-703 (PMID16585446, DOI10.1176/appi.ajp.163.4.697)
(en) C. Maravelias, A. Dona, M. Stefanidou, C. Spiliopoulou, « Adverse effects of anabolic steroids in athletes. A constant threat », Toxicol Lett, vol. 158, no 3, , p. 167-75 (PMID16005168, DOI10.1016/j.toxlet.2005.06.005)
(en) T. Pagonis, N. Angelopoulos, G. Koukoulis, C. Hadjichristodoulou, « Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse », Eur. Psychiatry, vol. 21, no 8, , p. 551-62 (PMID16356691, DOI10.1016/j.eurpsy.2005.09.001)
(en) T. Pagonis, N. Angelopoulos, G. Koukoulis, C. Hadjichristodoulou, P. Toli, « Psychiatric and hostility factors related to use of anabolic steroids in monozygotic twins », Eur. Psychiatry, vol. 21, no 8, , p. 563-9 (PMID16529916, DOI10.1016/j.eurpsy.2005.11.002)
(en) C. Kuhn, « Anabolic steroids », Recent Prog. Horm. Res., vol. 57, , p. 411-34 (PMID12017555, lire en ligne)
(en) Cynthia M. Kuhn, « Anabolic Steroids », Recent Progress in Hormone Research, The Endocrine Society, no 57, , p. 411-434 (lire en ligne)
jcem.endojournals.org
(en) S. Basaria, J. Wahlstrom, A. Dobs, « Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases », J. Clin. Endocrinol. Metab., vol. 86, no 11, , p. 5108–17 (PMID11701661, lire en ligne)
(en) E. Moore, A. Wisniewski, A. Dobs, « Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects », J. Clin. Endocrinol. Metab., vol. 88, no 8, , p. 3467–73 (PMID12915619, lire en ligne)
(en) J. Hoffman, N. Ratamess, « Medical Issues Associated with Anabolic Steroid Use: Are they Exaggerated? », Journal of Sports Science and Medicine, (lire en ligne [PDF], consulté le )
(en) Andrew Parkinson, Nick Evans, « Anabolic-Androgenic Steroids: A Survey of 500 Users », Medicine & Science in Sports & Exercise, American College of Sports Medicine, vol. 38, no 4, , p. 644-651 (PMID16679978, lire en ligne, consulté le )
(en) M. Medraś, U. Tworowska, « Treatment strategies of withdrawal from long-term use of anabolic-androgenic steroids », Pol Merkur Lekarski, vol. 11, no 66, , p. 535-8. (PMID11899857)
(en) J. Dony, A. Smals, R. Rolland, B. Fauser et C. Thomas, « Effect of lower versus higher doses of tamoxifen on pituitary-gonadal function and sperm indices in oligozoospermic men », Andrologia, vol. 17, no 4, , p. 369-78. (PMID3931502)
(en) C. Kuhn, « Anabolic steroids », Recent Prog. Horm. Res., vol. 57, , p. 411-34 (PMID12017555, lire en ligne)
(en) J. Hoberman, C. Yesalis, « The history of synthetic testosterone », Scientific American, vol. 272, no 2, , p. 76–81 (PMID7817189)
(en) E. Freeman, D. Bloom, E. McGuire, « A brief history of testosterone », Journal of Urology, vol. 165, , p. 371–373 (PMID11176375)
(en) R. Calfee R, P. Fadale, « Popular ergogenic drugs and supplements in young athletes », Pediatrics, vol. 117, no 3, , e577-89 (PMID16510635, DOI10.1542/peds.2005-1429)
(en) K. Pereira de Jésus-Tran, P. Côté, L. Cantin, J. Blanchet, F. Labrie, R. Breton, « Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity », Protein Sci., vol. 15, no 5, , p. 987-99 (PMID16641486, DOI10.1110/ps.051905906)
(en) D. Lavery, I. McEwan, « Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations », Biochem. J., vol. 391, no Pt 3, , p. 449-64 (PMID16238547, DOI10.1042/BJ20050872, lire en ligne)
(en) F. Hartgens, H. Kuipers, « Effects of androgenic-anabolic steroids in athletes », Sports Med, vol. 34, no 8, , p. 513-54 (PMID15248788)
(en) C. Roselli, « The effect of anabolic-androgenic steroids on aromatase activity and androgen receptor binding in the rat preoptic area », Brain Res, vol. 792, no 2, , p. 271–6 (PMID9593936)
(en) B. Cheskis, « Regulation of cell signalling cascades by steroid hormones », J. Cell. Biochem., vol. 93, no 1, , p. 20-7 (PMID15352158)
(en) I. Brodsky, P. Balagopal, K. Nair, « Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study », J. Clin. Endocrinol. Metab., vol. 81, no 10, , p. 3469-75. (PMID8855787)
(en) R. Hickson, S. Czerwinski, M. Falduto, A. Young, « Glucocorticoid antagonism by exercise and androgenic-anabolic steroids », Med Sci Sports Exerc, vol. 22, no 3, , p. 331-40 (PMID2199753)
(en) R. Singh, J. Artaza, W. Taylor, N. Gonzalez-Cadavid, S. Bhasin, « Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway », Endocrinology, vol. 144, no 11, , p. 5081-8. (PMID12960001)
(en) E. Schroeder, A. Vallejo, L. Zheng et al., « Six-week improvements in muscle mass and strength during androgen therapy in older men », J Gerontol A Biol Sci Med Sci, vol. 60, no 12, , p. 1586-92 (PMID16424293)
(en) C. Grunfeld, D. Kotler, A. Dobs, M. Glesby, S. Bhasin, « Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study », J Acquir Immune Defic Syndr, vol. 41, no 3, , p. 304-14 (PMID16540931)
(en) A. Giorgi, R. Weatherby, P.Murphy, « Muscular strength, body composition and health responses to the use of testosterone enanthate: a double blind study », Journal of science and medicine in sport / Sports Medicine Australia, vol. 2, no 4, , p. 341-55 (PMID10710012)
(en) F. Grace F, N. Sculthorpe, J. Baker, B. Davies, « Blood pressure and rate pressure product response in males using high-dose anabolic-androgenic steroids (AAS) », J Sci Med Sport, vol. 6, no 3, , p. 307-12 (PMID14609147)
(en) E. Barrett-Connor, « Testosterone and risk factors for cardiovascular disease in men », Diabete Metab, vol. 21, no 3, , p. 156-61 (PMID7556805)
(en) C. Bagatell, R. Knopp R, W. Vale, J. Rivier, W. Bremner, « Physiologic testosterone levels in normal men suppress high-density lipoprotein cholesterol levels », Ann Intern Med, vol. 116, no 12 Pt 1, , p. 967-73 (PMID1586105)
(en) C. Mewis, I. Spyridopoulos, V. Kühlkamp, L. Seipel, « Manifestation of severe coronary heart disease after anabolic drug abuse », Clinical cardiology, vol. 19, no 2, , p. 153-5 (PMID8821428)
(en) B. Melnik, T. Jansen, S.Grabbe, « Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem », Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, vol. 5, no 2, , p. 110-7 (PMID17274777, DOI10.1111/j.1610-0387.2007.06176.x)
(en) B. De Piccoli, F. Giada, A. Benettin, F. Sartori, E. Piccolo, « Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function », Int J Sports Med, vol. 12, no 4, , p. 408-12 (PMID1917226)
(en) M. Sullivan, C. Martinez, E. Gallagher, « Atrial fibrillation and anabolic steroids », The Journal of emergency medicine, vol. 17, no 5, , p. 851-7 (PMID10499702)
(en) R. Dickerman, F. Schaller, W. McConathy, « Left ventricular wall thickening does occur in elite power athletes with or without anabolic steroid Use », Cardiology, vol. 90, no 2, , p. 145-8 (PMID9778553)
(en) K. George, L. Wolfe, G. Burggraf, « The "athletic heart syndrome". A critical review », Sports medicine (Auckland, N.Z.), vol. 11, no 5, , p. 300-30 (PMID1829849)
(en) R. Dickerman, F. Schaller, N. Zachariah, W. McConathy, « Left ventricular size and function in elite bodybuilders using anabolic steroids », Clin J Sport Med, vol. 7, no 2, , p. 90-3 (PMID9113423)
(en) R. Salke, T. Rowland, E. Burke, « Left ventricular size and function in body builders using anabolic steroids », Medicine and science in sports and exercise, vol. 17, no 6, , p. 701-4 (PMID4079743)
(en) Y. Yamamoto, R. Moore, H. Hess, G. Guo, F. Gonzalez, K. Korach, R. Maronpot, M. Negishi, « Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity », J Biol Chem, vol. 281, no 24, , p. 16625-31 (PMID16606610)
(en) L. Socas, M. Zumbado, O. Pérez-Luzardoet al., « Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature », British journal of sports medicine, vol. 39, no 5, , e27 (PMID15849280, DOI10.1136/bjsm.2004.013599)
(en) I. Velazquez, B. Alteret al., « Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions », Am. J. Hematol., vol. 77, no 3, , p. 257-267 (PMID15495253, DOI10.1002/ajh.20183)
(en) R. Marcus et S. Korenman, « Estrogens and the human male », Annual Review of Medicine, vol. 27, , p. 357-70 (PMID779604, lire en ligne)
(en) M. Meriggiola, A. Costantino, W. Bremner et A. Morselli-Labate, « Higher testosterone dose impairs sperm suppression induced by a combined androgen-progestin regimen », J Androl, vol. 23, no 5, , p. 684-690 (PMID12185103)
(en) A. Matsumoto, « Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production », J. Clin. Endocrinol. Metab., vol. 70, no 1, , p. 282-7 (PMID2104626)
(en) M. Alén, M. Reinilä, R. Vihko, « Response of serum hormones to androgen administration in power athletes », Medicine and science in sports and exercise, vol. 17, no 3, , p. 354-9 (PMID2991700)
(en) M. Manikkam, E. Crespi, D. Doop et al., « Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep », Endocrinology, vol. 145, no 2, , p. 790-8 (PMID14576190)
(en) L. Irving, M. Wall, D. Neumark-Sztainer, M.Story, « Steroid use among adolescents: findings from Project EAT », The Journal of adolescent health: official publication of the Society for Adolescent Medicine, vol. 30, no 4, , p. 243-52 (PMID11927236)
(en) S. Basaria, J. Wahlstrom, A. Dobs, « Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases », J. Clin. Endocrinol. Metab., vol. 86, no 11, , p. 5108–17 (PMID11701661, lire en ligne)
(en) M. Ranke, J. Bierich, « Treatment of growth hormone deficiency », Clinics in endocrinology and metabolism, vol. 15, no 3, , p. 495–510 (PMID2429792)
(en) C. Grunfeld, D. Kotler, A. Dobs, M. Glesby, S. Bhasin, « Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study », J. Acquir. Immune Defic. Syndr., vol. 41, no 3, , p. 304-14 (PMID16540931)
(en) J. Berger, L. Pall, C. Hall, D. Simpson, P. Berry, R. Dudley, « Oxandrolone in AIDS-wasting myopathy », AIDS, vol. 10, no 14, , p. 1657-62 (PMID8970686)
(en) S. Arslanian, C. Suprasongsin, « Testosterone treatment in adolescents with delayed puberty: changes in body composition, protein, fat, and glucose metabolism », J. Clin. Endocrinol. Metab., vol. 82, no 10, , p. 3213-20 (PMID9329341)
(en) A. Aribarg, N. Sukcharoen, Y. Chanprasit, J. Ngeamvijawat, R. Kriangsinyos, « Suppression of spermatogenesis by testosterone enanthate in Thai men », Journal of the Medical Association of Thailand = Chotmaihet thangphaet, vol. 79, no 10, , p. 624-9 (PMID8996996)
(en) A. Kenny, K. Prestwood, C. Gruman, K. Marcello, L. Raisz, « Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels », J Gerontol A Biol Sci Med Sci., vol. 56, no 5, , M266-72 (PMID11320105)
(en) N. Baum, C. Crespi, « Testosterone replacement in elderly men », Geriatrics, vol. 62, no 9, , p. 14-8 (PMID17824721)
(en) R. Francis, « Androgen replacement in aging men », Calcif Tissue Int., vol. 69, no 4, , p. 235-8 (PMID11730258)
(en) K. Nair, R. Rizza, P. O'Brien et al., « DHEA in elderly women and DHEA or testosterone in elderly men », N Engl J Med, vol. 355, no 16, , p. 1647-59 (PMID17050889, DOI10.1056/NEJMoa054629)
(en) K. Shah, C. Montoya, R. Persons, « Do testosterone injections increase libido for elderly hypogonadal patients? », The Journal of family practice, vol. 56, no 4, , p. 301-5 (PMID17403329)
(en) A. Yassin, F. Saad, « Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only », The journal of sexual medicine, vol. 4, no 2, , p. 497-501 (PMID17367445)
(en) S. Arver, A. Dobs, A. Meikle et al., « Long-term efficacy and safety of a permeation-enhanced testosterone transdermal system in hypogonadal men », Clin. Endocrinol. (Oxf), vol. 47, no 6, , p. 727-37 (PMID9497881)
(en) E. Nieschlag, D. Büchter, S. Von Eckardstein et al., « Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men », Clin. Endocrinol. (Oxf), vol. 51, no 6, , p. 757-63 (PMID10619981)
(en) E. Moore, A. Wisniewski, A. Dobs, « Endocrine treatment of transsexual people: a review of treatment regimens, outcomes, and adverse effects », J. Clin. Endocrinol. Metab., vol. 88, no 8, , p. 3467–73 (PMID12915619, lire en ligne)
(en) C. Yesalis, N. Kennedy, A. Kopstein, M. Bahrke, « Anabolic-androgenic steroid use in the United States », JAMA, vol. 270, no 10, , p. 1217-21 (PMID8355384)
(en) S. McCabe, K. Brower, B. West, T. Nelson, H. Wechsler, « Trends in non-medical use of anabolic steroids by U.S. college students: Results from four national surveys », Drug and alcohol dependence, vol. 90, nos 2-3, , p. 243-51 (PMID17512138, DOI10.1016/j.drugalcdep.2007.04.004)
(en) Andrew Parkinson, Nick Evans, « Anabolic-Androgenic Steroids: A Survey of 500 Users », Medicine & Science in Sports & Exercise, American College of Sports Medicine, vol. 38, no 4, , p. 644-651 (PMID16679978, lire en ligne, consulté le )
(en) J. Cohen, R. Collins, J. Darkes, D. Gwartney, « A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States », feedback, (PMID17931410)
(en) J. Copeland, R. Peters, P. Dillon, « A study of 100 anabolic-androgenic steroid users », Med J. Aust., vol. 168, no 6, , p. 311-2 (PMID9549549)
(en) G. Kanayama, S. Barry, J. Hudson, H. Pope, « Body image and attitudes toward male roles in anabolic-androgenic steroid users », The American journal of psychiatry, vol. 163, no 4, , p. 697-703 (PMID16585446, DOI10.1176/appi.ajp.163.4.697)
(en) R. Hickson, S. Czerwinski, M. Falduto, A. Young, « Glucocorticoid antagonism by exercise and androgenic-anabolic steroids », Medicine and science in sports and exercise, vol. 22, no 3, , p. 331-40. (PMID2199753)
(en) C. Mutzebaugh, « Does the choice of alpha-AAS really make a difference? », HIV Hotline, vol. 8, nos 5-6, , p. 10-1 (PMID11366379)
(en) P. Kokkinos, P. Narayan, J. Colleran et al., « Effects of regular exercise on blood pressure and left ventricular hypertrophy in African-American men with severe hypertension », N. Engl. J. Med., vol. 333, no 22, , p. 1462-7. (PMID7477146)
(en) P. Plourde, E. Reiter, H. Jou et al., « Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial », J. Clin. Endocrinol. Metab., vol. 89, no 9, , p. 4428-33. (PMID15356042)
(en) K. Kaufman, E. Olsen, D. Whiting et al. Hair Loss Study Group, « Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern », J Am Acad Dermatol, vol. 39, no 4 Pt 1, , p. 578-89 (PMID9777765)
(en) S. Bhasin, T. Storer, N. Berman et al., « The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men », N Engl J Med, vol. 335, no 1, , p. 1-7 (PMID8637535)
(en) E. Schroeder, A. Vallejo, L. Zheng et al., « Six-week improvements in muscle mass and strength during androgen therapy in older men », J. Gerontol. A Biol. Sci. Med. Sci., vol. 60, no 12, , p. 1586-92. (PMID16424293)
(en) C. Grunfeld, D. Kotler, A. Dobs, M. Glesby, S. Bhasin, « Oxandrolone in the treatment of HIV-associated weight loss in men: a randomized, double-blind, placebo-controlled study », J Acquir Immune Defic Syndr, vol. 41, no 3, , p. 304–14. (PMID16540931)
(en) S. Bhasin, L. Woodhouse, R. Casaburi et al., « Testosterone dose-response relationships in healthy young men », Am J Physiol Endocrinol Metab, vol. 281, no 6, , E1172-81. (PMID11701431)
(en) C. Maravelias, A. Dona, M. Stefanidou, C. Spiliopoulou, « Adverse effects of anabolic steroids in athletes. A constant threat », Toxicol Lett, vol. 158, no 3, , p. 167-75 (PMID16005168, DOI10.1016/j.toxlet.2005.06.005)
(en) Uzych L, « Anabolic-androgenic steroids and psychiatric-related effects: a review », Canadian journal of psychiatry. Revue canadienne de psychiatrie, vol. 37, no 1, , p. 23-8. (PMID1551042)
(en) Pope H, Katz D, « Affective and psychotic symptoms associated with anabolic steroid use », The American journal of psychiatry, vol. 145, no 4, , p. 487-90. (PMID3279830)
(en) P. Fudala, R. Weinrieb, J. Calarco et al., « An evaluation of anabolic-androgenic steroid abusers over a period of 1 year: seven case studies », Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, vol. 15, no 2, , p. 121-30. (PMID12938869)
(en) Bahrke MS, Yesalis CE, Wright JE, « Psychological and behavioural effects of endogenous testosterone and anabolic-androgenic steroids. An update », Sports medicine (Auckland, N.Z.), vol. 22, no 6, , p. 367-90. (PMID8969015)
(en) J. Dalby, « Brief anabolic steroid use and sustatined behavioral reaction », American Journal of Psychiatry, vol. 149, no 3, , p. 271-272+1616 (PMID1734751)
(en) Harrison G. Pope, Elena M. Kouri, James I. Hudson, « Effects of Supraphysiologic Doses of Testosterone on Mood and Aggression in Normal Men », Med Sci Sports Exerc, Arch Gen Psychiatry, vol. 57, no 2, , p. 133-140. (PMID10665615, lire en ligne, consulté le )
(en) T. Pagonis, N. Angelopoulos, G. Koukoulis, C. Hadjichristodoulou, « Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse », Eur. Psychiatry, vol. 21, no 8, , p. 551-62 (PMID16356691, DOI10.1016/j.eurpsy.2005.09.001)
(en) T. Pagonis, N. Angelopoulos, G. Koukoulis, C. Hadjichristodoulou, P. Toli, « Psychiatric and hostility factors related to use of anabolic steroids in monozygotic twins », Eur. Psychiatry, vol. 21, no 8, , p. 563-9 (PMID16529916, DOI10.1016/j.eurpsy.2005.11.002)
(en) P. Perry, E. Kutscher, B. Lund et al., « Measures of aggression and mood changes in male weightlifters with and without androgenic anabolic steroid use », J Forensic Sci, vol. 48, no 3, , p. 646-51. (PMID12762541)
(en) R. Tricker, R. Casaburi, T. Storer et al., « The effects of supraphysiological doses of testosterone on angry behavior in healthy eugonadal men--a clinical research center study », J. Clin. Endocrinol. Metab., vol. 81, no 10, , p. 3754-8 (PMID8855834)
(en) D. O'Connor, J. Archer, W. Hair, F. Wu, « Exogenous testosterone, aggression, and mood in eugonadal and hypogonadal men », Physiol Behav, vol. 75, no 4, , p. 557-66. (PMID12062320)
(en) M. Walters, R. Ayers, D. Brown, « Analysis of illegally distributed anabolic steroid products by liquid chromatography with identity confirmation by mass spectrometry or infrared spectrophotometry », Journal - Association of Official Analytical Chemists, vol. 73, no 6, , p. 904-26. (PMID2289923)
pubmedcentral.nih.gov
(en) D. Lavery, I. McEwan, « Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations », Biochem. J., vol. 391, no Pt 3, , p. 449-64 (PMID16238547, DOI10.1042/BJ20050872, lire en ligne)
